Melissa Ray
FDA investigator
Appears on 3 documents from 2022 to 2025, most often at sites in Lithuania. Most often cites control of microbiological contamination (21 CFR 211.113).
- 3
- Documents on file
- 5.0
- Observations per 483
- 2022
- First seen
- 2025
- Most recent
What they cite most
From 11 observations- 21 CFR 211.113Control of microbiological contamination5
- 21 CFR 211.160General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.42Design and construction features1
- 21 CFR 211.63Equipment design, size, and location1
- 21 CFR 211.67Equipment cleaning and maintenance1
Activity by year
2022: 1, 2025: 2
Where
Lithuania 1 · South Korea 1
Often inspects with
Is Melissa Ray coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-09-18 | 483 Biotechnologinés farmacijos centras Biotechpharma Mokslininku str. 4Sep 18, 2025 · Vilnius, Lithuania | Vilnius, Lithuania | 2 | |
| 2025-04-04 | 483 Lonza AGApr 4, 2025 | — | — | |
| 2022-03-10 | 483 Janssen Vaccines Corp.Mar 10, 2022 · Incheon, South Korea | Incheon, South Korea | 8 |
About this profile
What does Melissa Ray inspect?
Melissa Ray appears on 3 documents on file covering 3 sites, most often in Lithuania.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.160 and 21 CFR 211.192.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Melissa Ray is dated Sep 18, 2025.